Ishaan Bio Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 16-11-2024
- Paid Up Capital ₹ 1.48 M
as on 16-11-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 44.31 Cr
as on 16-11-2024
- Revenue -3.37%
(FY 2023)
- Profit -26.61%
(FY 2023)
- Ebitda -81.44%
(FY 2023)
- Net Worth 8.43%
(FY 2023)
- Total Assets 10.28%
(FY 2023)
About Ishaan Bio
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.48 M.
The company currently has active open charges totaling ₹44.31 Cr.
Dipal Palkhiwala, Ishita Palkhiwala, Shreeraj Palkhiwala, and One other member serve as directors at the Company.
- CIN/LLPIN
U73200GJ2011PLC064359
- Company No.
064359
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ishaan Bio?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shreeraj Palkhiwala  | Additional Director | 13-Feb-2024 | Current |
| Dipal Palkhiwala | Director | 11-Mar-2011 | Current |
| Ishita Palkhiwala | Director | 11-Mar-2011 | Current |
| Anushree Palkhiwala | Additional Director | 13-Feb-2024 | Current |
Financial Performance of Ishaan Bio.
Ishaan Bio Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.37% decrease. The company also saw a substantial fall in profitability, with a 26.61% decrease in profit. The company's net worth moved up by a moderate rise of 8.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ishaan Bio?
In 2023, Ishaan Bio had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ishaan Nutricare Private LimitedActive 3 years 11 monthsDipal Palkhiwala, Shreeraj Palkhiwala and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 16 Sep 2022 | ₹19.83 Cr | Open |
Bank Of India Creation Date: 30 Mar 2022 | ₹1.95 Cr | Open |
Bank Of India Creation Date: 30 Oct 2021 | ₹7.70 M | Open |
How Many Employees Work at Ishaan Bio?
Ishaan Bio has a workforce of 25 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ishaan Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ishaan Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
